aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Scientific Intake, founded to address the global obesity epidemic, focuses on developing and commercializing innovative medical devices for weight management. Their core mission is to provide non-invasive, effective solutions for patients struggling with excess weight. The flagship product, Sensor Monitored Alimentary Restriction Therapy (SMART), is an oral device designed to aid in appetite control and satiety, leveraging biological mechanisms to support weight loss. The company targets markets in the United States, Canada, Europe, and Australia.
Notable figures affiliated with Scientific Intake include experts in medical device development and weight management. The company has attracted significant investment from health-focused venture capital firms. Key achievements include regulatory approvals in multiple regions and successful clinical trials demonstrating the efficacy of their SMART device. Overall, Scientific Intake has made a substantial impact by offering a novel, non-invasive approach to weight management, contributing to the broader fight against obesity.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices
Technology
HealthTech
Tags
SaaS, Healthcare
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Scientific Intake founded?
Scientific Intake was founded in 2003.
Where is Scientific Intake’s headquarters located?
Scientific Intake’s headquarters is located in Atlanta, GA, US.
When was Scientific Intake’s last funding round?
Scientific Intake’s most recent funding round was for $2.9M (USD) in April 2018.
How many employees does Scientific Intake have?
Scientific Intake has 8 employees as of Feb 5, 2024.
How much has Scientific Intake raised to-date?
As of July 05, 2023, Scientific Intake has raised a total of $8.2M (USD) since Apr 23, 2018.
Add Comparison
Total Raised to Date
$8.2M
USD
Last Update Apr 23, 2018
Last Deal Details
$2.9M
USD
Apr 23, 2018
Series Unknown
Total Employees Over Time
8
As of Feb 2024
Scientific Intake Address
3575 Piedmont Road NE
Atlanta,
Georgia
30305
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts